Web Analytics

3 Latest Announced Rounds

  • $4,200,000
    Seed

    5 Investors

    Technology, Information and Internet
    Jun 5th, 2025
  • $9,142,230
    Seed

    1 Investors

    Software Development
    Jun 5th, 2025
  • $4,800,000
    Series A

    1 Investors

    Information Technology & Services
    Jun 5th, 2025
$915.37M Raised in 54 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Artax Biopharma Inc

start up
United States - Cambridge, MA
  • 07/08/2024
  • Unknown
  • $8,000,000

Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases. Artax Biopharma is developing the next generation of drugs targeting the interaction between TCR and Nck, which is responsible for T cell activation. Specific control over T cells through TCR, provides the compounds with the potential to become first-in-class immunomodulators for the treatment of a wide range of autoimmune and inflammatory diseases.


Related People

Rob ArmstrongFounder

Rob Armstrong United States - Greater Boston

N/A